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Blood-stream infections (BSI) are associated with high mortality and morbidity world-wide. 
The most common aetiological agent of these infections is Escherichia coli. The rise of multi-
drug resistant (MDR) E. coli is a major concern in clinical medicine and needs to be monitored 
for implementation of infection control strategies. The misuse of antimicrobials in clinical 
treatment, and as growth promotors in food-producing animals, is a key component of the rapid 
evolution of MDR E. coli. MDR organisms spread antimicrobial resistance and virulence 
factors by lateral gene transfer via mobile genetic elements (MGEs). Despite this, there is 
limited knowledge of the origins and underlying mechanisms of BSI MDR E. coli infections 
in Australia.  
 
We conducted genomic epidemiological analyses of E. coli from human blood-cultures 
collected from a Sydney teaching hospital. The collection was dominated by E. coli causing 
community onset BSI, with clones carrying a plethora of virulence and antimicrobial resistance 
genes. Clinical class 1 integrons associated with IS26 were identified in a number of sequence 
types (ST), indicating that they are important drivers of evolution and spread of clinically 
important antimicrobial resistance genes. We identified IncFII-IncFIB plasmids in the majority 
of our collection. A number of STs harboured ColV like IncFII plasmids, carry a number of 
important virulence traits, were also identified. We observed a novel ST, ST8196, that clustered 
with globally disseminated E. coli ST131 isolates. We also identified an emerging ST, ST38, 
that exhibited resistance to a broad range of clinical beta-lactamases that have been identified 
in a number of pandemic E. coli isolates.  
 
Our study provides evidence that E. coli BSIs in Australia have a reservoir of antimicrobial 
resistance and virulence determinants that are potentially circulating not only in the community 
and hospital settings but across agricultural settings. These genes are not only present to clinical 
settings but can circulate within different ecosystems potentially via plasmids or other MGEs. 
Our findings also reveal that there are specific antimicrobial resistance genes such as ESBLs 
that are found in dominant E. coli clones in both humans and food producing animals. This is 
likely to occur due the overuse of antimicrobials in human and animal settings that is driving 
the increase in antimicrobial resistance among bacteria that cause diseases. It is therefore 
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essential to rigorously monitor these infections to help manage the global problem of 
antimicrobial resistance, and to reduce or prevent disease outbreaks. 
 
